The Ministry of Health confirms that the arrival of the swine flu virus resistant to Tamiflu, to Egypt .. The World Health Organization announces invasion of England and America .. And horror of the speed of its spread
Saturday, December 5th, 2009 - 13:25
Minister of Health Dr.. Hatem mountain
Princess wrote Abdel-Salam - Photo: Maherixander
The announcement of WHO on the transmission of swine influenza virus resistant to treatment with Altammivloa for the first time since the discovery of the virus, to open the door to a new wave of evolution of the virus, which experts said was a new virus that no one knows the nature of the prevalence or Thorath and resistance to treatment.
For its part, the Ministry of Health in Egypt in a quick response on the evolution of transmission of resistant virus, that so far does not appear, the pattern of drug resistance to treatment Altammivloa between any of the cases in Egypt, both of which mirrored a cure or who died of infection with swine influenza, indicating the a statement that it is working to monitor and examine all the cases to see any pattern or resistant to the virus mutated, stating that there had been a slight mutation in the nature of the virus in Egypt, but that the rate of mutation is disturbing and do not affect either the treatment or prevention with Tamiflu anti-serum to him.
The Ministry of Health formed a committee to examine the death of the tenth case, due to the injury of swine flu, which was suspected of resistance to treatment Baltammivloa, but it has not yet been proved.
The WHO has indicated in published urgent this morning, it had registered for the first time two cases of infection caused by H1N1 viruses resistant to oseltamivir, the scientific name of the property wizard to swine influenza virus to "Altammivloa."
The first group launched by the fascist "and Wales" which was recorded in England, which was unveiled in late October last eight patients, was the introduction of all these patients to the hospital because of bloody unrest and tent. Has not been recorded any deaths among them so far, note that being treated and one of them in the intensive care ward.
The second group is a fascist United States of America, which included four patients with a general shortage of Immunology, The cases occurred over two weeks in the period between mid-October and early November of last November, has resulted in three cases of a total of four cases of death, but that uncertainty does not continues to control the extent to which the H1N1 virus in the occurrence of such deaths.
Included all viruses H275Y resistance mutation itself, which refers to the resistance to the drug oseltamivir treatment of influenza first mutated and sensitivity about zanamivir, a drug the second anti-virus software.
The World Health Organization, once receiving reports, to organize a telephone conference with officials of the hospitals and their staff and experts in the fields of clinical medicine, epidemiology and virology to discuss the outbreaks mentioned, calling attention therapeutic options that can be made available to the immunocompromised patients who are infected with HIV pandemic.
It is noticeable that the two groups of cases, which were detected them in Wales, United Kingdom and North Carolina, USA, appeared on the wing of one hospital and attached both patients with impaired immune defenses. It was suspected that the virus, each able to infection among these patients.
The emergence of influenza viruses resistant to drugs with severe by the vulnerability or the lack of those who were treated with antiviral medicines are not excluded from the things that have been documented during epidemics of seasonal influenza.
And continue as predicted transmission of the virus in these patients for long periods, despite antiretroviral therapy, thus contributing to creating a conducive environment to accelerate the emergence of drug-resistant viruses have been observed this phenomenon also in a pandemic (H1N1) 2009, which led to the decline of many other viruses before swine flu virus mutated, and Dr. Zuhair Hallaj, WHO consultant in Cairo, stressing that the mutation of the most important characteristics of influenza viruses and no one knows what the nature of contagion, or mutate, pointing to the need to control the virus to find out the main attributes of the new.
The outbreaks are being investigated in depth to determine the pattern of transmission within the wing, and make sure that transmission of resistant viruses to health care workers and other patients who are in the hospitals concerned, or to society in general, and the results reached so far are reassuring .. Terms not disclosed the existence of any medical conditions among health workers who provide care to the patients described, suggesting that the resistant virus does not spread easily to healthy people not infected with other diseases, especially in the application of sound measures to combat the infection, also did not find surveillance intensive for any spread of the virus to other wards in the hospitals concerned or within the general community.
For their part, agreed that the WHO experts who study the situation on the need to treat patients who suffer from severe shortages in the immune vulnerable groups in particular,
And that those patients Itzmon heavily exposed to infection and the difficulty of treatment and the possible development of HIV drug resistance to them.
The experts also agreed on the need for physicians who treat these patients a high level of security against influenza-virus infection, and the commitment of special vigilance to be able to monitor the rapid development of resistance, which may appear to oseltamivir.
It is unlikely that doses of oseltamivir and the standard treatment period was sufficient for those patients, despite the importance of refraining from power only after clinical evaluation, it may be increased doses and extended treatment period, without stopping for stage acute and zanamivir should be considered appropriate treatment for people with influenza, which lasts for extended periods, despite receiving treatment Balooseltamifir.
The organization also announced that it had been detected the virus resistant to oseltamivir in one of the wings treating patients who suffer severe shortages in the immune system, clinicians should consider the possibility of transition to zanamivir for use as a medicine, is the first choice anti-virus and also be used as a treatment after exposure prophylaxis to protect other patients who on the wing effect.
The experts stressed, the recommendation that they produced by the World Health Organization on the need to vaccinate health care workers and people who care for patients and contacts of patients from their families against influenza pandemic.
World Health Organization recommends the need to be vigilant in monitoring the evolution of viruses resistant to oseltamivir, and monitor any changes in the viability of these viruses on the transmission and Imraditha. Show experience in the field of seasonal influenza viruses that resistant viruses can spread and become established quickly among the public and render effective drugs to them.
For his part, Minister of Health Dr. Hatem the Minister of Health began vaccinating all workers in the medical field, whether public or private sectors through the remaining doses of the second installment of anti-serum of swine flu, in addition to the allocation of the third installment of the full serum Tattiym medical staff ensure the end of December year.
As it turns out the experience gained since the first identification of the characteristics of pandemic H1N1 virus in March, that the inhibitors oseltamivir and zanamivir, contribute to - when given in early stages - in reducing the risk of complications, may also contribute to improving clinical outcomes in people with severe cases. It highlights the experience the need to preserve the efficacy of both drugs mentioned limitation, to the lowest level possible, the likelihood of the emergence of resistance towards them and the impact of such resistance.
The WHO has received the first report on the existence of a pandemic virus resistant to oseltamivir in July last year, it was observed that in general the cases resistant to oseltamivir appeared sporadically geographically and randomly without any connection among them, and the number of such cases has increased steadily unparalleled increases have been reported recently in influenza activity in the many regions of the world and give more anti-retroviral drugs.
The number of cases documented cases of H1N1 viruses resistant to oseltamivir during the past two weeks, an increase of 57 cases to 96 cases, and there was a third of those cases among patients with weakened immune system due to malignant tumors, blood or chemical treatment fierce anti-cancer treatments or one of the following transplantation.
Saturday, December 5th, 2009 - 13:25
Minister of Health Dr.. Hatem mountain
Princess wrote Abdel-Salam - Photo: Maherixander
The announcement of WHO on the transmission of swine influenza virus resistant to treatment with Altammivloa for the first time since the discovery of the virus, to open the door to a new wave of evolution of the virus, which experts said was a new virus that no one knows the nature of the prevalence or Thorath and resistance to treatment.
For its part, the Ministry of Health in Egypt in a quick response on the evolution of transmission of resistant virus, that so far does not appear, the pattern of drug resistance to treatment Altammivloa between any of the cases in Egypt, both of which mirrored a cure or who died of infection with swine influenza, indicating the a statement that it is working to monitor and examine all the cases to see any pattern or resistant to the virus mutated, stating that there had been a slight mutation in the nature of the virus in Egypt, but that the rate of mutation is disturbing and do not affect either the treatment or prevention with Tamiflu anti-serum to him.
The Ministry of Health formed a committee to examine the death of the tenth case, due to the injury of swine flu, which was suspected of resistance to treatment Baltammivloa, but it has not yet been proved.
The WHO has indicated in published urgent this morning, it had registered for the first time two cases of infection caused by H1N1 viruses resistant to oseltamivir, the scientific name of the property wizard to swine influenza virus to "Altammivloa."
The first group launched by the fascist "and Wales" which was recorded in England, which was unveiled in late October last eight patients, was the introduction of all these patients to the hospital because of bloody unrest and tent. Has not been recorded any deaths among them so far, note that being treated and one of them in the intensive care ward.
The second group is a fascist United States of America, which included four patients with a general shortage of Immunology, The cases occurred over two weeks in the period between mid-October and early November of last November, has resulted in three cases of a total of four cases of death, but that uncertainty does not continues to control the extent to which the H1N1 virus in the occurrence of such deaths.
Included all viruses H275Y resistance mutation itself, which refers to the resistance to the drug oseltamivir treatment of influenza first mutated and sensitivity about zanamivir, a drug the second anti-virus software.
The World Health Organization, once receiving reports, to organize a telephone conference with officials of the hospitals and their staff and experts in the fields of clinical medicine, epidemiology and virology to discuss the outbreaks mentioned, calling attention therapeutic options that can be made available to the immunocompromised patients who are infected with HIV pandemic.
It is noticeable that the two groups of cases, which were detected them in Wales, United Kingdom and North Carolina, USA, appeared on the wing of one hospital and attached both patients with impaired immune defenses. It was suspected that the virus, each able to infection among these patients.
The emergence of influenza viruses resistant to drugs with severe by the vulnerability or the lack of those who were treated with antiviral medicines are not excluded from the things that have been documented during epidemics of seasonal influenza.
And continue as predicted transmission of the virus in these patients for long periods, despite antiretroviral therapy, thus contributing to creating a conducive environment to accelerate the emergence of drug-resistant viruses have been observed this phenomenon also in a pandemic (H1N1) 2009, which led to the decline of many other viruses before swine flu virus mutated, and Dr. Zuhair Hallaj, WHO consultant in Cairo, stressing that the mutation of the most important characteristics of influenza viruses and no one knows what the nature of contagion, or mutate, pointing to the need to control the virus to find out the main attributes of the new.
The outbreaks are being investigated in depth to determine the pattern of transmission within the wing, and make sure that transmission of resistant viruses to health care workers and other patients who are in the hospitals concerned, or to society in general, and the results reached so far are reassuring .. Terms not disclosed the existence of any medical conditions among health workers who provide care to the patients described, suggesting that the resistant virus does not spread easily to healthy people not infected with other diseases, especially in the application of sound measures to combat the infection, also did not find surveillance intensive for any spread of the virus to other wards in the hospitals concerned or within the general community.
For their part, agreed that the WHO experts who study the situation on the need to treat patients who suffer from severe shortages in the immune vulnerable groups in particular,
And that those patients Itzmon heavily exposed to infection and the difficulty of treatment and the possible development of HIV drug resistance to them.
The experts also agreed on the need for physicians who treat these patients a high level of security against influenza-virus infection, and the commitment of special vigilance to be able to monitor the rapid development of resistance, which may appear to oseltamivir.
It is unlikely that doses of oseltamivir and the standard treatment period was sufficient for those patients, despite the importance of refraining from power only after clinical evaluation, it may be increased doses and extended treatment period, without stopping for stage acute and zanamivir should be considered appropriate treatment for people with influenza, which lasts for extended periods, despite receiving treatment Balooseltamifir.
The organization also announced that it had been detected the virus resistant to oseltamivir in one of the wings treating patients who suffer severe shortages in the immune system, clinicians should consider the possibility of transition to zanamivir for use as a medicine, is the first choice anti-virus and also be used as a treatment after exposure prophylaxis to protect other patients who on the wing effect.
The experts stressed, the recommendation that they produced by the World Health Organization on the need to vaccinate health care workers and people who care for patients and contacts of patients from their families against influenza pandemic.
World Health Organization recommends the need to be vigilant in monitoring the evolution of viruses resistant to oseltamivir, and monitor any changes in the viability of these viruses on the transmission and Imraditha. Show experience in the field of seasonal influenza viruses that resistant viruses can spread and become established quickly among the public and render effective drugs to them.
For his part, Minister of Health Dr. Hatem the Minister of Health began vaccinating all workers in the medical field, whether public or private sectors through the remaining doses of the second installment of anti-serum of swine flu, in addition to the allocation of the third installment of the full serum Tattiym medical staff ensure the end of December year.
As it turns out the experience gained since the first identification of the characteristics of pandemic H1N1 virus in March, that the inhibitors oseltamivir and zanamivir, contribute to - when given in early stages - in reducing the risk of complications, may also contribute to improving clinical outcomes in people with severe cases. It highlights the experience the need to preserve the efficacy of both drugs mentioned limitation, to the lowest level possible, the likelihood of the emergence of resistance towards them and the impact of such resistance.
The WHO has received the first report on the existence of a pandemic virus resistant to oseltamivir in July last year, it was observed that in general the cases resistant to oseltamivir appeared sporadically geographically and randomly without any connection among them, and the number of such cases has increased steadily unparalleled increases have been reported recently in influenza activity in the many regions of the world and give more anti-retroviral drugs.
The number of cases documented cases of H1N1 viruses resistant to oseltamivir during the past two weeks, an increase of 57 cases to 96 cases, and there was a third of those cases among patients with weakened immune system due to malignant tumors, blood or chemical treatment fierce anti-cancer treatments or one of the following transplantation.
Last edited by a moderator:
